Delivery Order SPE2DP20D0002-SPE2DP24F2835
Award Date 2/22/24
Potential Completion Date 2/27/24
Potential Value $159K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024 and does not utilize a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. This delivery order has a completion date of January 30, 2024. Teva Pharmaceuticals USA, Inc. is the prime contractor and there is no set-aside designation for this award. The company has previously fulfilled multiple federal contracts and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This vaccine supports military immunization programs. The contract has an ultimate completion date of August 27, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drug products to various U.S. federal government agencies,...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $330,313.86, is for the delivery of Adenovirus Type 4 vaccines to support military immunization programs. Teva Pharmaceuticals USA, Inc. is a major supplier of critical pharmaceutical products to federal agencies, including the Department of Veterans Affairs...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,270,437.84 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc. to provide Adenovirus Type 4 vaccines. Teva is a large, foreign-owned pharmaceutical manufacturer that has fulfilled numerous federal contracts for critical medical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs for agencies such as the Department of Veterans Affairs (VA) and Department of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 A vaccine. The contract has a completion date of January 30, 2024 and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts to supply critical pharmaceutical products to the Department of...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 award is to provide Adenovirus Type 4 vaccine, with an ultimate completion date of March 26, 2024. Teva Pharmaceuticals USA is an experienced federal contractor, having been awarded numerous prime contracts and delivery orders by agencies such as the Department of Veterans...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccines. This order has a completion date of January 30, 2024 and is not a set-aside contract. Teva Pharmaceuticals USA, Inc. provides critical pharmaceutical products to federal agencies like the Department of Veterans Affairs (VA), Department of Defense (DOD),...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency's Troop Support Medical division to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The $317,609.46 contract has an ultimate completion date of December 3, 2024 and is not set aside for any particular business type. Teva Pharmaceuticals is a major supplier of critical medical products, including vaccines, to various federal...